Aehr director exercises options, sells 8,000 shares

Aehr Test Systems director Fariba Danesh exercised options and sold shares in a linked transaction.

Rhea-AI Filing Summary

Aehr Test Systems director Fariba Danesh exercised options and sold shares in a linked transaction. Danesh exercised 8,000 Non-Qualified Options for Common Stock at $2.25 per share, then sold 8,000 Common shares at an average price of $82.63 on the same date.

After these transactions, Danesh directly holds 13,143 Common shares, and the reported amount includes shares subject to unvested restricted stock units. No derivative options remain from this specific grant following the exercise.

Insider Trade Summary

Exercise and Sale: 8,000 shares ($643K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider DANESH FARIBA

Role Director

Sold 8,000 shs ($661K)

Approx. gross sale proceeds $661K

Approx. exercise cost $18K

Approx. pre-tax spread $643K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Option (right to buy)	8,000	$0.00	$0.00
Exercise	Common Stock	8,000	$2.25	$18K
Sale	Common Stock	8,000	$82.63	$661K

Holdings After Transaction: Non-Qualified Option (right to buy) — 0 contracts (Direct); Common Stock — 13,143 shares (Direct)

Footnotes (1)

1. F1. The amount reported includes shares subject to unvested restricted stock units.

Key Figures

Options exercised: 8,000 shares Exercise price: $2.25 per share Shares sold: 8,000 shares +3 more

6 metrics

Options exercised 8,000 shares Non-Qualified Option exercise into Common Stock

Exercise price $2.25 per share Strike price for 8,000 options exercised

Shares sold 8,000 shares Common Stock open-market or private sale

Sale price $82.63 per share Average price for 8,000 Common shares sold

Shares owned after 13,143 shares Direct Common Stock holdings following transactions

Option expiration May 10, 2028 Original expiration date of exercised Non-Qualified Options

Key Terms

Non-Qualified Option (right to buy), derivative security, open-market sale, restricted stock units

4 terms

Non-Qualified Option (right to buy) financial

"Security title is listed as Non-Qualified Option (right to buy)"

derivative security financial

"transaction_code_description notes Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

open-market sale financial

"transaction_action is described as open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

restricted stock units financial

"footnote states amount reported includes shares subject to unvested restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AEHR director Fariba Danesh do in this Form 4 filing?

Fariba Danesh exercised stock options for 8,000 Aehr Test Systems shares at $2.25 and then sold 8,000 Common shares at $82.63. The filing shows a typical exercise-and-sell sequence, converting an option position into cash while retaining a remaining equity stake.

How many AEHR shares did Fariba Danesh sell and at what price?

Fariba Danesh sold 8,000 shares of Aehr Test Systems Common Stock at an average price of $82.63 per share. This sale followed the exercise of 8,000 options, effectively disposing of the newly acquired shares in an open-market or private transaction.

What option exercise is reported for AEHR director Fariba Danesh?

The filing shows Danesh exercised 8,000 Non-Qualified Options to buy Aehr Test Systems Common Stock at $2.25 per share. These options, originally granted with a 2028 expiration, were converted into 8,000 Common shares and then fully sold on the same transaction date.

How many AEHR shares does Fariba Danesh own after these transactions?

After the reported transactions, Fariba Danesh directly owns 13,143 shares of Aehr Test Systems Common Stock. The filing notes that this amount includes shares subject to unvested restricted stock units, meaning some of the reported holdings are still subject to vesting conditions.

Does Fariba Danesh still hold any AEHR stock options from this grant?

From this specific option grant, Danesh no longer holds any derivative options after exercising 8,000 Non-Qualified Options. The exercise reduced the derivative position to zero, converting it fully into Common Stock, which was then sold in the same reporting period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 08:40 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DANESH FARIBA

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/16/2026		M		8,000	A	$2.25	21,143	D
Common Stock	04/16/2026		S		8,000	D	$82.63	13,143(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Option (right to buy)	$2.25	04/16/2026		M			8,000	06/10/2021	05/10/2028	Common Stock	8,000	$0	0	D

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)